Real-Time Stock News, Analysis & Price Movements

Eli Lilly and Company News - February 26, 2026

Eli Lilly Widens Lead in Obesity Market as Wall Street Bets on Oral GLP-1 Pipeline
LLY

Eli Lilly Widens Lead in Obesity Market as Wall Street Bets on Oral GLP-1 Pipeline

JPMorgan, Deutsche Bank, and RBC Capital reiterated their confidence in Eli Lilly’s leadership within the expanding obesity treatment market. The investment...
Lilly’s Oral Orforglipron Outperforms Novo’s Semaglutide in Landmark Head-to-Head Trial
LLY

Lilly’s Oral Orforglipron Outperforms Novo’s Semaglutide in Landmark Head-to-Head Trial

Eli Lilly’s experimental once-daily oral drug, orforglipron, demonstrated superior efficacy over Novo Nordisk’s oral semaglutide in a Phase 3 head-to-head...